famotidine has been researched along with Dyskinesia, Medication-Induced in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SAO | 1 |
| Xia, R | 1 |
| Ding, Y | 1 |
| Won, L | 1 |
| Ray, WJ | 1 |
| Hitchcock, SA | 1 |
| McGehee, DS | 1 |
| Kang, UJ | 1 |
1 other study available for famotidine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
Topics: Action Potentials; Animals; Cholinergic Neurons; Corpus Striatum; Dicyclomine; Disease Models, Anima | 2015 |